{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:50:55Z","timestamp":1789411855932,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20234Y0215"],"award-info":[{"award-number":["20234Y0215"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503540"],"award-info":[{"award-number":["82503540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.labinv.2026.106124","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:21:29Z","timestamp":1775604089000},"page":"106124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low\/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors"],"prefix":"10.1016","volume":"106","author":[{"given":"Xiaoyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-7083","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2026.106124_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41571-024-00914-x","article-title":"Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer","volume":"21","author":"Sen","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semcancer.2022.04.001","article-title":"Small cell lung cancer: subtypes and therapeutic implications","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.labinv.2026.106124_bib3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Ganti","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.labinv.2026.106124_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaoncol.2022.5631","article-title":"Emerging strategies for the treatment of small cell lung cancer: a review","volume":"9","author":"Petty","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00408-021-00486-y","article-title":"Update 2021: management of small cell lung cancer","volume":"199","author":"Tariq","year":"2021","journal-title":"Lung"},{"key":"10.1016\/j.labinv.2026.106124_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.labinv.2026.106124_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtho.2016.12.004","article-title":"The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential diagnosis. An international reproducibility study in a demanding set of cases","volume":"12","author":"Thunnissen","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2026.106124_bib9","first-page":"620","article-title":"Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.labinv.2026.106124_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.labinv.2026.106124_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.labinv.2026.106124_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40164-024-00548-w","article-title":"Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities","volume":"13","author":"Zhang","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/molecules30081731","article-title":"Molecular subtypes and targeted therapeutic strategies in small cell lung cancer: advances, challenges, and future perspectives","volume":"30","author":"Huang","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.labinv.2026.106124_bib14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gad.314815.118","article-title":"POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer","volume":"32","author":"Huang","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.labinv.2026.106124_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAS.0000000000002313","article-title":"Expression of POU2F3 transcription factor and POU2AF2, POU2F3 coactivator, in tuft cell-like carcinoma and other tumors","volume":"49","author":"Kaczorowski","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2026.106124_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2026.106124_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","article-title":"POU2F3 in SCLC: clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC","volume":"17","author":"Baine","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000002081","article-title":"POU2F3: a sensitive and specific diagnostic marker for neuroendocrine-low\/negative small cell lung cancer","volume":"47","author":"Wang","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2026.106124_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-025-01690-6","article-title":"Current and future therapies for small cell lung carcinoma","volume":"18","author":"Zhai","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000519688","article-title":"Small-cell carcinoma of the lung: what we learned about it?","volume":"66","author":"Righi","year":"2022","journal-title":"Acta Cytol"},{"key":"10.1016\/j.labinv.2026.106124_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jtho.2020.11.006","article-title":"YAP1 expression in SCLC defines a distinct subtype with T-cell-inflamed phenotype","volume":"16","author":"Owonikoko","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.labinv.2026.106124_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PAS.0000000000001977","article-title":"Molecular classification of extrapulmonary neuroendocrine carcinomas with emphasis on POU2F3-positive tuft cell carcinoma","volume":"47","author":"Koh","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.labinv.2026.106124_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1158\/2159-8290.CD-24-0286","article-title":"Chromothripsis-mediated small cell lung carcinoma","volume":"15","author":"Rekhtman","year":"2025","journal-title":"Cancer Discov"}],"updated-by":[{"DOI":"10.1016\/j.labinv.2026.106140","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:41:45Z","timestamp":1782477705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0023683726000541"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106124","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low\/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106124"}}